Risk behaviour

There has been concern that the availability of PEP for sexual and IDU exposures might paradoxically increase risk behaviour. However most studies have in fact shown that people take fewer sexual risks after having taken PEP, probably because the experience made them re-evaluate their behaviour. Nonetheless there are fears that if PEP becomes a standard and repeated prevention resource, a subset of high-risk people may become complacent about risk if repeated PEP is seen as a routine solution to exposure cases.

A study from Guy’s and St Thomas’ hospitals in London presented at the 2010 BHIVA/BASHH conference1 looked at behaviour change in 83 gay men given PEP. At six months, the proportion of gay men reporting risky sex in the previous three months declined significantly from 51% at baseline to 8.7%. The proportion reporting new sexually transmitted infections in the previous three months dropped, from 16.7% at three months to 8.7% at six months. Twelve-month results will be published later.

One San Francisco programme addressed these concerns by giving 457 PEP patients five sessions of risk reduction counselling.2 The study found that two sessions of counselling achieved a statistically significant reduction in risk exposures among ‘lower-risk’ patients (those having had risky sex no more than four times before the request for PEP), but that it took five sessions to achieve a reduction in risk among patients who had had more exposures.

In the study, only 10% of people seeking PEP reported an increase in risk behaviour following a PEP consultation whereas 74% reported a decrease in risk behaviour and 16% reported no change.

References

  1. Loke WC et al. The impact of taking HIV post-exposure prophylaxis after sexual exposure (PEPSE) on sexual behaviour. Second BHIVA/BASHH Joint Conference, Manchester, abstract P99, 2010
  2. Roland ME et al. A randomized trial of standard versus enhanced risk reduction counselling for individuals receiving post-exposure prophylaxis following sexual exposure to HIV. Thirteenth Conference on Retroviruses and Opportunistic Infections, Denver, abstract 902, 2006
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.